Dallas, Texas
Sleep disorder clinical trials in Dallas, TX
11 sleep disorder studies are recruiting participants at sites in Dallas as of November 16, 2026, according to ClinicalTrials.gov. Sleep Study Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Dallas at a glance
- 11 studies are recruiting at a site in Dallas.
- By phase: Phase 2 (1), Phase 2/3 (2), Phase 3 (4), No phase (3), Observational (1). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (9), university, hospital or other (2).
- By research area: Narcolepsy (5), Sleep Apnea (5), Insomnia (1).
- Most recent update to one of these records: November 13, 2026.
Insomnia studies recruiting in Dallas
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Improving Sleep Quality During Pregnancy Using an Oral Appliance
- No phase
- Ages 18 to 45
- Female participants
- Sponsor
- Texas A&M University
- Study site
- Texas A&M University College of Dentistry
- Registry record
- NCT03646214 · updated
Source: ClinicalTrials.gov. Data processed . See every insomnia study recruiting in Dallas, TX on ClinicalTrials.gov.
Sleep apnea studies recruiting in Dallas
DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Incannex Healthcare Ltd
- Study site
- FutureSearch Trials of Dallas
- Registry record
- NCT07635563 · updated
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study site
- Velocity Clinical Research, Dallas
- Registry record
- NCT07823608 · updated
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
- No phase
- Ages 2 to 17
- All sexes
- Sponsor
- Oregon Health and Science University
- Study site
- UT Southwestern Medical Center
- Registry record
- NCT05508971 · updated
Severe Label Expansion for EVO Products Trial
- No phase
- Ages 18 to 80
- All sexes
- Sponsor
- ProSomnus Sleep Technologies
- Study site
- Star Sleep and Wellness
- Registry record
- NCT07090395 · updated
Pediatric Post-Approval Registry
- Observational
- Ages 18 to 21
- All sexes
- Sponsor
- Inspire Medical Systems, Inc.
- Study site
- University of Texas Southwestern/Children's Hospital of Dallas
- Registry record
- NCT04457154 · updated
Source: ClinicalTrials.gov. Data processed . See every sleep apnea study recruiting in Dallas, TX on ClinicalTrials.gov.
Narcolepsy studies recruiting in Dallas
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Harmony Biosciences Management, Inc.
- Study site
- Southwest Family Medicine
- Registry record
- NCT07675135 · updated
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Phase 2/3
- Ages 18 to 70
- All sexes
- Sponsor
- Centessa Pharmaceuticals (UK) Limited
- Study site
- Dallas, Texas
- Registry record
- NCT07598708 · updated
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Phase 2/3
- Ages 18 to 70
- All sexes
- Sponsor
- Alkermes, Inc.
- Study site
- Alkermes Investigational Site
- Registry record
- NCT06767683 · updated
A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Jazz Pharmaceuticals
- Study site
- FutureSearch Trials of Dallas
- Registry record
- NCT07625280 · updated
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
- Phase 3
- Ages 18 to 70
- All sexes
- Sponsor
- Alkermes, Inc.
- Study site
- Alkermes Investigational Site
- Registry record
- NCT07540897 · updated
Source: ClinicalTrials.gov. Data processed . See every narcolepsy study recruiting in Dallas, TX on ClinicalTrials.gov.
Ask about studies near Dallas
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Texas
All Texas locations
38 studies recruiting across 19 cities.
San Antonio
16 studies recruiting.
Austin
15 studies recruiting.
Houston
12 studies recruiting.
Sugar Land
10 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Sleep Study Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections